METROMIDOL Drug Patent Profile
✉ Email this page to a colleague
When do Metromidol patents expire, and what generic alternatives are available?
Metromidol is a drug marketed by Labs Af and is included in one NDA.
The generic ingredient in METROMIDOL is metronidazole. There are eighteen drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Metromidol
A generic version of METROMIDOL was approved as metronidazole by TEVA PHARMS USA on November 6th, 1984.
Summary for METROMIDOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 172 |
| Patent Applications: | 3,923 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | METROMIDOL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for METROMIDOL
US Patents and Regulatory Information for METROMIDOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Labs Af | METROMIDOL | metronidazole | TABLET;ORAL | 074523-001 | Oct 24, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Labs Af | METROMIDOL | metronidazole | TABLET;ORAL | 074523-002 | Oct 24, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
